Owner Fujisawa Pharmaceutical Co., Ltd.

Inventors Morita, Masataka; Ishida, Junya; Nakai, Kazuo; Eikyu, Yoshiteru; Azami, Hidenori; Kayakiri, Natsuko; Shigenaga, Shinji; Konishi, Nobukiyo; Take, Kazuhiko

Agent Davies Collison Cave

Pub. Number AU-A-2004201111

Parent 768652

Filing date 16 March 2004

Wipo publication date 22 April 2004

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 027/02 Drugs for disorders of the senses

A61P 003/00 Drugs for disorders of the metabolism

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/535 - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

C07F 007/18 Compounds containing elements of the 4th Group of the Periodic System

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 403/06 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 401/06 Heterocyclic compounds containing two or more hetero rings